NuVasive and orthopedic devicemaker SMAIO mutually decided to end their software co-development efforts, according to a Jan. 27 news release.
In the first quarter of 2022, SMAIO and NuVasive, a global leader in spine technology innovation, entered into a development and license agreement to further advance SMAIO’s surgical planning ...
The stock carries a Zacks Rank #2 (Buy) currently. Globus Medical merged its business with NuVasive. The combined company has ...
Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. However, a challenging macroeconomic scenario continues to plague Globus Medical. The stock ...
DALLAS & LYON, France, January 27, 2025--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker ...
SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA ...
In the first quarter of 2022, SMAIO and NuVasive, a global leader in spine technology innovation, entered into a development and license agreement to further advance SMAIO’s surgical planning ...